• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Affera's Technology For Cardiac Arrhythmia Treatment To Be Highlighted In 17 Scientific Sessions At The 2019 Heart Rhythm Society Meeting


News provided by

Affera, Inc.

May 06, 2019, 17:00 ET

Share this article

Share this article


WATERTOWN, Mass., May 6, 2019 /PRNewswire/ -- Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform will be highlighted in seventeen scientific sessions at the Heart Rhythm Society 2019 (HRS) meeting in San Francisco.

Affera's revolutionary lesion formation and mapping platform offers a solution designed to optimize procedural efficiency and efficacy across a broad range of arrhythmias. The expandable lattice tip of the company's Sphere9™ catheter and integrated system enable the rapid creation of detailed maps as well as controlled, durable lesions in a variety of substrates.

"It has been exciting to participate in the development of Affera's technology and to translate this work from pre-clinical studies to patient care," stated Elad Anter, M.D., Director of Electrophysiology Laboratories at Beth Israel Deaconess and Associate Professor of Medicine at Harvard Medical School. "In the initial clinical experience treating Atrial Fibrillation, the system shows extraordinary promise in achieving pulmonary vein isolation with less than three minutes of radiofrequency time. The ability to design and create lines of block such as the cavo-tricuspid and mitral isthmus lines, typically with only seconds of energy delivery, is game-changing.  Furthermore, I am enthusiastic about the impact Affera will have on Ventricular Tachycardia treatment, which currently represents a truly unmet clinical need."

"Affera is pleased to return to HRS this year to share initial clinical results from our work with leading investigators in Europe, and highlight additional capabilities of our system," stated Doron Harlev, CEO and founder of Affera. "We are excited by the clinical community's reception of our technology and look forward to further validation as we work to expand our clinical efforts to the US."

Schedule:

Tuesday, May 7th (Stanford Biodesign New Arrhythmia Technologies Retreat)
8:18 AM: "Irrigated Temperature Controlled Lattice Ablation Catheter" by Jacob S. Koruth, MD
4:02 PM:  "A Novel Expandable Lattice Electrode Ablation Catheter Rapidly Produces Wide Radiofrequency Lesions with Low Risk of Thrombus and Steam Pop" by Hiroshi Nakagawa, MD, PhD

Wednesday, May 8th
10:00 AM: "PV Isolation: Techniques to Achieve Permanent PV Isolation using RF Energy" by Vivek Reddy, MD (S-AF01)
2:45 PM: "The New Era of High Fidelity Atrial Mapping" by Hiroshi Nakagawa, MD, PhD (S-ET03)
4:00 PM: "Delivery of High-Power Short Duration Radiofrequency Energy" by Vivek Reddy, MD (S-ET04)
5:00 PM: "Rapid Linear Ablation Across The Cavo-tricuspid Isthmus And Mitral Isthmus Using A Novel Expandable Lattice Radiofrequency Electrode Mapping/ablation System: Rapid Confirmation Of Conduction Block By Real-time Propagation Vector Mapping (first-in-man Trial)" by Hiroshi Nakagawa, MD, PhD (S-PO01-046)

Thursday, May 9th
8:00 AM: "A Novel Expandable Lattice Electrode Ablation Catheter Produces Wide and Deep Radiofrequency Lesions with Low Risk of Steam Pop or Thrombus" by Atsushi Ikeda, MD (S-AB07-01)
8:15 AM: "Rapid Pulmonary Vein Isolation Using An Irrigated Temperature-controlled Lattice Ablation Catheter: A First-in-human Clinical Experience" by Vivek Reddy, MD (S-AB08-02)
9:30 AM: "A Novel Irrigated Temperature-Controlled Lattice Ablation Catheter for Deep Ventricular Substrate: A Preclinical Biophysical Characterization" by Ayelet Shapira-Daniels, MD (S-IA01-010)
9:30 AM: "Achieving Rapid Conduction Block In The Mitral Isthmus: Pre-clinical And First-in-human Clinical Experience With A Novel Temperature-controlled Irrigated Catheter" by Syeda Batul, MD (S-PO02-149)
9:30 AM: "Pre-clinical And First-in-human Experience Using A Novel Lattice-tip Temperature-controlled Irrigated Radiofrequency Ablation Catheter: Rapid Bidirectional Block In The Cavo-tricuspid Isthmus" by Mohit Turagam, MD (S-PO02-150)
9:30 AM: "A Novel Expandable Lattice Electrode Ablation Catheter Produces Wide and Deep Radiofrequency Lesions with Low Risk of Steam Pop or Thrombus" by Atsushi Ikeda, MD (S-IA01-028)
12:15 PM: "A Novel Irrigated Temperature-Controlled Lattice Ablation Catheter for Deep Ventricular Substrate: A Preclinical Biophysical Characterization" by Ayelet Shapira-Daniels, MD (S-WEP-03)
2:00 PM: "Real-time Propagation Vector Mapping In A Novel Mapping/ablation System Using Close Unipolar Electrodes" by Hiroshi Nakagawa, MD, PhD (S-PO03-118)
2:30 PM: "Deep Radiofrequency Lesion Formation with Low Risk of Steam Pop and Thrombus" by Hiroshi Nakagawa, MD, PhD (S-JS04)

Friday, May 10th
8:00 AM: "A Novel Irrigated Temperature-Controlled Lattice Ablation Catheter for Deep Ventricular Substrate: A Preclinical Biophysical Characterization" by Ayelet Shapira-Daniels, MD (S-AB25-01)

Saturday, May 11th 
8:54 AM: "Temperature Controlled RF Ablation Will Result in Faster Procedure Times" by Hiroshi Nakagawa, MD, PhD (S-101)

About Affera Inc.
Affera Inc. is a medical technology company dedicated to developing innovative solutions to address the rapidly growing cardiac arrhythmia market.  Affera is developing an integrated solution to efficiently deliver durable therapy for cardiac arrhythmia patients. The Affera system is not currently approved for commercial use. For more information, please visit www.affera.com.

MEDIA CONTACT:
Jordan Valley
Affera, Inc.
857-304-4030
[email protected]
www.affera.com

SOURCE Affera, Inc.

Related Links

https://www.affera.com

Modal title

Also from this source

Affera Announces First Patient Treated in SPHERE Per-AF IDE Trial...

Affera Announces First Patient Treated in SPHERE Per-AF IDE Trial...

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Medical Pharmaceuticals
  • Biotechnology
  • Trade Show News
  • Clinical Trials & Medical Discoveries

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.